Can Natural Structural Analogues of Antimicrobials be Repurposed as External Use Disinfectants? A Small Scale Industry’s Experience in India During Pandemics
DOI:
https://doi.org/10.14738/jbemi.91.11721Keywords:
Repurposed oral drugs; Structural analogues of natural product Antimicrobials; External use non-alcoholic disinfectants formulations; Industrial experience in a developing nationAbstract
This opinion article highlights the experience of a small group of textile entrepreneurs in India despite the economic downturn during the pandemic crisis and diversified to a small scale healthcare industry. By not only having innovated a way out of their set-backs, but also utilising a proof of concept industry-led study, they have repurposed macromolecular natural product structural analogues for external use applications such as protective antimicrobial coating for domestic and healthcare fabric laundering, and as disinfectant in places with a heavy footfall (e.g. mass / rapid transport systems, hospitality sector) in developing nations. Furthermore, natural antimicrobial analogues supplied at nanomolar dosage, this prototype product adds no burden to either environmental toxicity or antimicrobial resistance. A collaborative interplay of the industry with academia and pharmaceutical researchers would heighten the science of this industries unique approach of a different kind of ‘ drug repurposing’ to underpin a practical working solution for long-term disinfection beyond the contagion pandemics to both public and healthcare utilities in economically challenged developing nations.
References
Millar B. C. Moore J.E., and Rao, J. R. Fighting antimicrobial resistance (AMR): Chinese herbal medicine as a source of novel antimicrobials – an update, Letters in Applied Microbiology 2021. 73(4) p 400-407. doi: 10.1111/lam.13534 https://doi.org/10.1111/lam.13534
Nelson, D., J. E. Moore and J. R Rao. Antimicrobial resistance (AMR): Significance to food quality & safety, Food Quality and Safety, 2019. 3(1) p 15–22. https://doi.org/10.1093/fqsafe/fyz003
Malnarcic, C.M., et al., Quality of antibiotics in destinations, Travel Medicine and Infectious Disease, 2020. 38 p 1-3. https://doi.org/10.1016/j.tmaid.2020.101747
Nelson, D. Antimicrobials: Novel insights into plant health and biomedical applications. PhD Thesis. University of Ulster, Northern Ireland, U.K. 2017.
Moore, J. E., et al., Description of a simple bio-imaging technique to assess inhibition/growth promoting properties of novel agents on moulds. British Journal of Biomedical Science 2010. 67(3) p 145-146. https://doi.org/10.1080/09674845.2010.11730312
McIlroy, R., et al., Discovery of inhibition of Burkholderia cenocepacia, Pseudomonas aeruginosa and Stenotrophomonas maltophilia by the Brown Rot Basidiomycete Fungus, Postia placenta, Ulster Medical Journal, 2021. 90(3) p 168-174. https://www.ums.ac.uk/090_3.html
McIlroy, R., et al., Pseudomonas aeruginosa – Candida interplay: effect on in vitro antibiotic susceptibility of Pseudomonas aeruginosa when grown in the presence of Candida culture, British Journal of Biomedical Science, 2020. 77(4) p 1-5. https://doi.org/10.1080/09674845.2020.1819003
Millar, B.C., et al., Antimicrobial properties of Basidiomycota macrofungi to Mycobacterium abscessus isolated from patients with Cystic Fibrosis, International Journal of Mycobacteriology, 2019. 8(1) p 93-97. https://pubmed.ncbi.nlm.nih.gov/30860186/#:~:text=PMID%3A%2030860186,10.4103/ijmy.ijmy_167_18
Nelson D., et al., Antimicrobial properties of native Ulster macrofungi (mushrooms and toadstools) to clinical pathogens. Ulster Medical Journal 2019. 88 (2) p 128-132. ANTIMICROBIAL PROPERTIES OF NATIVE ULSTER MACROFUNGI (MUSHROOMS AND TOADSTOOLS) TO CLINICAL PATHOGENS (nih.gov)
Rao, J. R., et al., Antimicrobial properties of shiitake mushrooms (Lentinula edodes). International Journal of Antimicrobial Agents 2009. 33(6) p 591-592 https://doi.org/10.1016/j.ijantimicag.2008.10.018
Hearst, R., et al., An examination of the antibacterial and antifungal properties of constituents of shiitake (Lentinula edodes) and oyster (Pleurotus ostreatus) mushrooms. Complementary Therapies in Clinical Practice 2009. 15(1) p 5-7. https://doi.org/10.1016/j.ctcp.2008.10.002
Woods-Panzaru, S., An examination of antibacterial and antifungal properties of constituents described in traditional Ulster cures and remedies", Ulster Medical Journal, 2009. 78(1) p 13-15. http://www.ncbi.nlm.nih.gov/pmc/articles/pmc2629014/
Moore, P. J., et al., Examination of the antibacterial properties of sphagnum moss (Sphagnum spp.) and its significance with turf burning in Ireland, British Journal of Biomedical Science 2012. 69(4) p 178-18 https://pubmed.ncbi.nlm.nih.gov/23304795/#:~:text=4)%3A178%2D80.-,PMID%3A%2023304795.,-Copy
Efstratiou, E., et al., Antimicrobial activity of Callendula officinalis petal extracts against fungi, as well as Gram-ve and Gram+ve clinical pathogens. Complementary Therapies in Clinical Practice 2012. 18(3) p 173-176. https://pubmed.ncbi.nlm.nih.gov/22789794/#:~:text=PMID%3A%2022789794,j.ctcp.2012.02.003
Hearst, M., et al., An investigation into antimicrobial properties of protein extractions from native fungal and plant species, Journal of Pharmacognosy and Phytotherapy 2010. 2(8) p 103-107. http://www.academicjournals.org/jpp/abstracts/abstracts/abstracts2010/Dec/Hearst%20et%20al.htm
Toner, P., et al., Antimicrobial properties of phytohormone (gibberellins) against phytopathogens and clinical pathogens. Access Microbiology, 2021. 3 (10). DOI 10.1099/acmi.0.000278 https://doi.org/10.1099/acmi.0.000278
Chesborough, H., Recession is a time for innovation, 2010. Science Business Newsletter Recession is a time for innovation | Science|Business (sciencebusiness.net)
Fursenthal, L., et al., 2020. Healthcare innovation: Launchpad out of the covid-19 crisis Innovation in a crisis: Why it is more critical than ever | McKinsey
Moore, J.E. and Rao, J.R. Efficacy of biocide Steri-7 against the common Gram negative bacterial pathogens Burkholderia cenocepacia, Burkholderia gladioli, Burkholderia multivoran and Pseudomonas aeroginosa, and Stenotrophomonas maltophilia associated with cystic Fibrosis (CF). British J Biomed Science 2013. 70(2) p 80-81. https://doi.org/10.1080/09674845.2013.11669940
Renaud, J-P Structural Biology in Drug Discovery: Methods, Techniques, and Practices, ed2020, pp Minneapolis, MN, United States, (John Wiley & Sons, Inc.). 600 DOI:10.1002/9781118681121. [21} Liu, J. et al., Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro, Nature Communications, 2020. Cell Discov 6, 16. https://doi.org/10.1038/s41421-020-0156-0www.nature.com/celldisc [22] Bakowski, M.A. et al., Drug repurposing screens identify chemical entities for the development of COVID-19 interventions. Nature Communications, 2021. https://doi.org/10.1038/s41467-021-23328-0 [23] Anonymous, Disinfectant use and Covid-19: list of antimicrobial products for use against SARS-CoV-2, 2020, Disinfectant Use and Coronavirus (COVID-19) | US EPA [24] Kampf, G., et al., Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents, 2020. Journal of Hospital Infection 104 (3) 246–251. DOI: 10.1016/j.jhin.2020.01.022 [25] van Doremalen et al., Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-2, New England Journal of Medicine 382:1564-1567 DOI: 10.1056/NEJMc2004973
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 JR Rao
This work is licensed under a Creative Commons Attribution 4.0 International License.
